Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024)

Mira Pharmaceuticals (MIRA) posted Current Leases of $1273.0 for Q1 2024, down 74.85% sequentially from $5061.0 in Q4 2023.

Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024) Analysis & Trends

Mira Pharmaceuticals has reported Current Leases for 3 years, with the latest figure at $1273.0 in Q1 2024.

Quarterly Current Leases changed N/A year-over-year to $1273.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1273.0 (changed N/A YoY) and the FY2023 annual result came in at $5061.0, down 97.45% from the prior year.
Current Leases declined to $1273.0 in Q1 2024 per MIRA's latest filing, from $5061.0 in the prior quarter.
Over five years, Current Leases peaked at $198759.0 in Q4 2022 and troughed at $1273.0 in Q1 2024.
A 3-year average of $70956.6 and a median of $74328.0 in 2023 frame the typical range for Current Leases.
The widest YoY moves for Current Leases: up 97.45% in 2023, down 97.45% in 2023.
Over 3 years, Current Leases stood at $198759.0 in 2022, then sank by 97.45% to $5061.0 in 2023, then tumbled by 74.85% to $1273.0 in 2024.
According to Business Quant data, Current Leases over the past three periods registered $1273.0, $5061.0, and $74328.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	-
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	-
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Mira Pharmaceuticals	18.47 Mn	7.44 Mn	-	-

Download Data